Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 6 of 6 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 12/27/17
End: 04/16/19
Due: 04/16/20
Phase: N/A
Priority: Normal
Start: 06/05/20
End: 05/05/23
Due: 05/05/24
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 06/23/21
Due: 06/23/22
Phase: N/A
Priority: Normal
Start: 03/07/24
End: 11/10/24
Due: 11/10/25
Phase: N/A
Priority: Normal
Start: 12/29/21
End: 03/31/25
Due: 03/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Web-based Genetic Research on Lupus | NCT02530944 | 23andMe, Inc. | user2@example.com | None | 2015-05-31 | 2017-10-31 | 2018-10-31 | - | - | 2025-07-14 |
| Web-based Weight Loss Intervention | NCT03400696 | 23andMe, Inc. | user2@example.com | None | 2017-12-27 | 2019-04-16 | 2020-04-16 | - | - | 2025-07-14 |
| 23andMe IPF Research Study | NCT05028894 | 23andMe, Inc. | user2@example.com | None | 2020-06-05 | 2023-05-05 | 2024-05-05 | - | - | 2025-07-14 |
| Web-based Genetic Research on Parkinson's Disease | NCT01351467 | 23andMe, Inc. | user2@example.com | None | 2009-04-30 | 2021-06-23 | 2022-06-23 | - | - | 2025-07-14 |
| Study of 23ME-01473 in Patients With Advanced Solid Malignancies | NCT06290388 | 23andMe, Inc. | user2@example.com | None | 2024-03-07 | 2024-11-10 | 2025-11-10 | - | - | 2025-07-14 |
| A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies | NCT05199272 | 23andMe, Inc. | user2@example.com | None | 2021-12-29 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |